FDA Inspection 1113084 — Sanofi Aventis Singapore Pte. Ltd.
The FDA completed an inspection of Sanofi Aventis Singapore Pte. Ltd. on Nov 1, 2019 in Singapore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 1, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Singapore (Singapore)